Beth P. Goldstein
Impact in
- Infectious Diseases top 0.5%
- Antifungal resistance and susceptibility
- Antimicrobial Resistance in Staphylococcus
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
Papers in
- Microbiology 12
- Antimicrobial Peptides and Activities 10
-
- Antimicrobial Resistance in Staphylococcus 21
- Antifungal resistance and susceptibility 10
- Co-authors
- David S. KrauseMichele WibleAdriano MalabarbaTim HenkelAnnette C. ReboliJennifer SchranzMaurizio DenaroElyse Seltzer
- Journals
- The Journal of Antibiotics (14 papers)Antimicrobial Agents and Chemotherapy (13 papers)Journal of Antimicrobial Chemotherapy (4 papers)Journal of Clinical Microbiology (4 papers)Clinical Infectious Diseases (3 papers)
- Partner nations
- United StatesItalyCanada
In The Last Decade
Beth P. Goldstein
74 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 139
- Infectious Diseases 2.2k
- Molecular Medicine 405
- Clinical Biochemistry 528
- Applied Microbiology and Biotechnology 150
- Pharmacology 939
Countries citing papers authored by Beth P. Goldstein
This map shows the geographic impact of Beth P. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth P. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth P. Goldstein more than expected).
Fields of papers citing papers by Beth P. Goldstein
This network shows the impact of papers produced by Beth P. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth P. Goldstein. The network helps show where Beth P. Goldstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Beth P. Goldstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 286 | |
| 2 | 2008 | 24 | |
| 3 | Anidulafungin versus Fluconazole for Invasive Candidiasis Hit paper breakdown → | 2007 | 618 |
| 4 | 2006 | 32 | |
| 5 | 2005 | 132 | |
| 6 | 2005 | 56 | |
| 7 | 2004 | 66 | |
| 8 | 2004 | 169 | |
| 9 | 1996 | 24 | |
| 10 | 1996 | 26 | |
| 11 | 1995 | 34 | |
| 12 | 1994 | 29 | |
| 13 | 1993 | 10 | |
| 14 | 1993 | 17 | |
| 15 | 1993 | 16 | |
| 16 | 1992 | 24 | |
| 17 | 1990 | 6 | |
| 18 | 1990 | 9 | |
| 19 | 1988 | 25 | |
| 20 | 1988 | 12 |
About Beth P. Goldstein
Beth P. Goldstein is a scholar working on Microbiology, Infectious Diseases, Clinical Biochemistry, Molecular Medicine and Pharmacology, having authored 74 papers that have together received 3.7k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (21 papers), Microbial Natural Products and Biosynthesis (16 papers), Bacterial Identification and Susceptibility Testing (12 papers), Antimicrobial Peptides and Activities (10 papers), Antifungal resistance and susceptibility (10 papers), Fungal Infections and Studies (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). The work is most often cited by research in Infectious Diseases (2.2k citations), Molecular Medicine (405 citations), Clinical Biochemistry (528 citations), Applied Microbiology and Biotechnology (150 citations) and Pharmacology (939 citations). Beth P. Goldstein has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include David S. Krause, Michele Wible, Adriano Malabarba, Tim Henkel, Annette C. Reboli, Jennifer Schranz, Maurizio Denaro, Elyse Seltzer, Stanley W. Chapman and Peter G. Pappas. Their work appears in journals such as The Journal of Antibiotics, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Journal of Clinical Microbiology and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.